Oscar Health (NYSE:OSCR) Insider Janet Liang Sells 10,360 Shares

Oscar Health, Inc. (NYSE:OSCR) insider Janet Liang sold 10,360 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $325,822.00. Following the completion of the transaction, the insider owned 248,697 shares of the company’s stock, valued at $7,821,520.65. This trade represents a 4.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Trading Up 2.0%

Shares of NYSE:OSCR opened at $32.90 on Wednesday. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $33.55. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The company’s fifty day simple moving average is $30.58 and its 200 day simple moving average is $23.01. The firm has a market cap of $10.15 billion, a price-to-earnings ratio of 23.50, a PEG ratio of 0.66 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last announced its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. The firm had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company’s revenue for the quarter was up 70.4% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.89) EPS. As a group, research analysts forecast that Oscar Health, Inc. will post 1.54 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently issued reports on OSCR. Barclays increased their price objective on Oscar Health from $35.00 to $39.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Piper Sandler restated an “overweight” rating and issued a $36.00 target price on shares of Oscar Health in a research note on Tuesday, July 28th. UBS Group upped their price target on Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Robert W. Baird set a $27.00 price target on shares of Oscar Health in a research note on Friday, August 7th. Finally, Weiss Ratings upgraded shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $26.22.

Key Oscar Health News

Here are the key news stories impacting Oscar Health this week:

• Neutral Sentiment: Director Mario Schlosser sold 31,422 shares for approximately $988,000 and retained 449,444 shares. Mario Schlosser SEC filing
• Neutral Sentiment: CFO Richard Blackley sold 28,869 shares valued at roughly $908,000, while continuing to own more than 1.04 million shares. Richard Blackley SEC filing
• Neutral Sentiment: Other insiders Adam Mcananey, Janet Liang and Chief Accounting Officer Victoria Baltrus sold approximately $642,000 combined. Each sale was also tied to tax obligations and represented only a modest reduction in their respective holdings. Adam Mcananey SEC filing Janet Liang SEC filing Victoria Baltrus SEC filing

Institutional Investors Weigh In On Oscar Health

Large investors have recently made changes to their positions in the stock. CoreCap Advisors LLC grew its stake in shares of Oscar Health by 526.3% in the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after buying an additional 1,000 shares in the last quarter. GAMMA Investing LLC increased its holdings in Oscar Health by 32.9% during the second quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock worth $41,000 after buying an additional 357 shares during the last quarter. Quarry LP raised its position in Oscar Health by 439.8% during the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after acquiring an additional 1,469 shares in the last quarter. FNY Investment Advisers LLC bought a new stake in Oscar Health during the second quarter worth $57,000. Finally, Allworth Financial LP lifted its stake in Oscar Health by 124.9% in the second quarter. Allworth Financial LP now owns 2,031 shares of the company’s stock valued at $58,000 after acquiring an additional 1,128 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.